PARIS, June 9, 2026 — In a remarkable counter-trend to Europe’s startup landscape, French health insurance technology company Alan has achieved a €5 billion valuation following a €100 million funding round. This milestone arrives as approximately 30% of European unicorns have reportedly lost their billion-dollar status over the past year. The Alan health insurance valuation surge represents a significant vote of confidence from investors including Index Ventures, Greenoaks, and notable business angels like Shopify founder Tobi Lütke and footballer Antoine Griezmann. The company now serves one million employees, freelancers, and retirees across multiple countries while approaching operational break-even.
Alan’s €5 Billion Valuation Defies European Startup Trends
The €5 billion valuation — approximately $5.83 billion — marks a substantial increase from Alan’s $4.5 billion valuation in 2024. According to company statements, this latest funding round was led by existing investor Index Ventures and joined by new investors Greenoaks, Kaaf, and SH. Belgian bank and insurance company Belfius, which led Alan’s previous Series F round, also participated. This funding success contrasts sharply with broader European startup data suggesting many unicorns have struggled to maintain valuations amid shifting market conditions.
Founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, Alan became the first new independent insurance company to receive a French license since the 1980s. The company has since grown to 740 employees while expanding its service offerings beyond basic health insurance. Alan’s app now enables users to manage reimbursements, access doctors through telemedicine services, and track health habits through integrated wellness features. This comprehensive approach has helped the company reach €785 million in annual recurring revenue for 2025, representing 53% growth from the end of 2024.
Strategic Expansion and Government Contracts Fuel Growth
Alan’s valuation milestone follows several strategic victories that have expanded its market presence and revenue streams. Most notably, the company secured a contract to provide health insurance to up to 135,000 French civil servants and their relatives. This government contract represents a significant expansion beyond Alan’s traditional private-sector client base and demonstrates growing institutional trust in the startup’s model.
- International Expansion: Alan has expanded operations into Belgium and Spain, where it counts HP and Volkswagen as clients, and more recently into Canada, where it is now licensed across all provinces.
- Revenue Growth: The company reported €785 million in annual recurring revenue for 2025, up 53% from 2024, while approaching operational break-even in its home market.
- Loss Reduction: After registering net losses of $61 million in 2023 and $56 million in 2024, Alan claims to have halved its losses as a percentage of revenue over the past 12 months.
CEO Outlines Ambitious AI Investment Strategy
In a statement following the funding announcement, CEO Jean-Charles Samuelian-Werve emphasized the company’s plans to “invest ambitiously, particularly in technology and artificial intelligence.” Samuelian-Werve’s background includes serving as a co-founding advisor and board member at French AI company Mistral AI, suggesting potential synergies between the two companies. This connection to France’s emerging AI ecosystem positions Alan uniquely within the European insurtech landscape.
Industry analysts point to Alan’s technology investments as a key differentiator. “Alan has consistently prioritized building proprietary technology rather than relying on legacy systems,” explains Dr. Isabelle Renault, a fintech researcher at the European School of Management and Technology. “Their early focus on creating a seamless digital experience, combined with recent AI investments, creates significant competitive advantages in customer acquisition and retention.”
European Insurtech Landscape: Alan’s Position in Context
Alan’s success stands in contrast to broader challenges facing European insurtech companies. While the sector attracted significant investment during the 2020-2023 period, many companies have struggled with profitability and sustainable growth models. Alan’s approach — combining insurance with wellness services and technology — appears to resonate with both consumers and institutional clients.
| Company | Country | Valuation (2026) | Key Differentiator |
|---|---|---|---|
| Alan | France | €5B | Integrated health/wellness platform, AI focus |
| Wefox | Germany | €4.5B (2024) | Broker platform, multiple insurance lines |
| Lemonade | US (EU operations) | $1.2B (market cap) | AI-driven claims, behavioral economics |
| Clark | Germany | €700M (2024) | Insurance manager app, comparison tools |
Future Trajectory: International Growth Over Immediate Profitability
Despite approaching break-even, Alan has signaled that international expansion and product improvements will take priority over immediate profitability. The company aims to reach $1.16 billion in annual recurring revenue by the end of 2026, a target that suggests continued aggressive growth. This strategy appears acceptable to investors, who have demonstrated confidence through the latest funding round.
Investor Confidence and Market Reactions
The participation of high-profile investors like Tobi Lütke and Antoine Griezmann, alongside established venture firms, indicates strong confidence in Alan’s long-term vision. “Alan represents a new generation of insurance companies that leverage technology to create better customer experiences,” said Martin Mignot, Partner at Index Ventures, in a separate statement. “Their growth trajectory, combined with their innovative approach to combining insurance and wellness services, positions them uniquely in the European market.”
Market observers note that Alan’s success comes amid increasing regulatory scrutiny of insurtech companies across Europe. The company’s early focus on obtaining proper licenses in each market it enters has positioned it well for sustainable expansion. This regulatory diligence contrasts with some competitors who have faced challenges when expanding across borders.
Conclusion
Alan’s €5 billion health insurance valuation milestone represents a significant achievement in the European startup ecosystem, particularly amid broader challenges facing unicorn companies. The company’s growth strategy — combining technology investments, international expansion, and a comprehensive approach to health services — has resonated with investors and customers alike. With plans to prioritize growth over immediate profitability and ambitious AI investments on the horizon, Alan appears positioned for continued expansion. The company’s success story offers insights into how European startups can navigate challenging market conditions while building sustainable, technology-driven businesses that address fundamental consumer needs in the healthcare and insurance sectors.
Frequently Asked Questions
Q1: What is Alan’s current valuation and how does it compare to previous years?
Alan is now valued at €5 billion (approximately $5.83 billion), up from $4.5 billion in 2024. This represents significant growth despite challenging conditions for many European unicorns.
Q2: What are Alan’s main sources of revenue and growth?
The company generates revenue primarily through health insurance premiums, serving one million employees, freelancers, and retirees. Recent growth has been fueled by a major contract with French civil servants and expansion into Belgium, Spain, and Canada.
Q3: How does Alan plan to use its latest funding?
CEO Jean-Charles Samuelian-Werve stated the company will “invest ambitiously, particularly in technology and artificial intelligence.” The funding will support both product development and international expansion efforts.
Q4: Is Alan profitable yet?
The company has reached operational profitability in France, its largest market, and is approaching overall break-even. However, Alan plans to prioritize growth and expansion over immediate full profitability, targeting $1.16 billion in annual recurring revenue by end of 2026.
Q5: What makes Alan different from other insurtech companies?
Alan combines health insurance with wellness services through its app, creating an integrated health platform. The company was also the first new independent insurance company to receive a French license since the 1980s, giving it regulatory advantages.
Q6: How does Alan’s success affect the broader European startup ecosystem?
Alan’s valuation milestone demonstrates that European startups can achieve significant scale while addressing fundamental needs in regulated industries. The company’s focus on sustainable growth and regulatory compliance offers a model for other startups in similar sectors.
